dactinomycin
Generic: dactinomycin
Labeler: eugia us llcDrug Facts
Product Profile
Brand Name
dactinomycin
Generic Name
dactinomycin
Labeler
eugia us llc
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
Active Ingredients
dactinomycin .5 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
55150-431
Product ID
55150-431_ea070887-e81e-4998-87ae-86f52718d003
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA203385
Listing Expiration
2026-12-31
Marketing Start
2021-03-15
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
55150431
Hyphenated Format
55150-431
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
dactinomycin (source: ndc)
Generic Name
dactinomycin (source: ndc)
Application Number
ANDA203385 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .5 mg/mL
Packaging
- 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-431-01) / 1 mL in 1 VIAL, SINGLE-DOSE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "ea070887-e81e-4998-87ae-86f52718d003", "openfda": {"nui": ["N0000180850", "N0000000233", "N0000000150"], "unii": ["1CC1JFE158"], "rxcui": ["239179"], "spl_set_id": ["aa047ee8-f2e8-4720-84b1-d1c4532d6c63"], "pharm_class_epc": ["Actinomycin [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Protein Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Eugia US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (55150-431-01) / 1 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "55150-431-01", "marketing_start_date": "20210315"}], "brand_name": "DACTINOMYCIN", "product_id": "55150-431_ea070887-e81e-4998-87ae-86f52718d003", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Actinomycin [EPC]", "Nucleic Acid Synthesis Inhibitors [MoA]", "Protein Synthesis Inhibitors [MoA]"], "product_ndc": "55150-431", "generic_name": "DACTINOMYCIN", "labeler_name": "Eugia US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DACTINOMYCIN", "active_ingredients": [{"name": "DACTINOMYCIN", "strength": ".5 mg/mL"}], "application_number": "ANDA203385", "marketing_category": "ANDA", "marketing_start_date": "20210315", "listing_expiration_date": "20261231"}